Bioscience

NIH funds grantees focusing on epigenomics of human health and disease

September 16, 2009

By Flinn Foundation

[Source: NIH] – The National Institutes of Health announced today that it will fund 22 grants on genome-wide studies of how epigenetic changes — chemical modifications to genes that result from diet, aging, stress, or environmental exposures — define and contribute to specific human diseases and biological processes.

The awards will build on the important work undertaken as part of the NIH Roadmap for Medical Research’s Epigenomics Program. Approximately $62 million will be awarded over the next five years to study the epigenome in a number of diseases and conditions, including tumor development, hardening of the arteries, autism, glaucoma, asthma, aging, and abnormal growth and development.

For more information NIH Funds Grantees Focusing on Epigenomics of Human Health and Disease